Most Download
1
Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary
(30 day view times: 53)
2024, 37(9): 949-992.
doi: 10.3967/bes2024.162
Since 1990, China has made considerable progress in resolving the problem of “treatment difficulty” of cardiovascular diseases (CVD). The prevalent unhealthy lifestyle among Chinese residents has exposed a massive proportion of the population to CVD risk factors, and this situation is further worsened due to the accelerated aging population in China. CVD remains one of the greatest threats to the health of Chinese residents. In terms of the proportions of disease mortality among urban and rural residents in China, CVD has persistently ranked first. In 2021, CVD accounted for 48.98% and 47.35% of deaths in rural and urban areas, respectively. Two out of every five deaths can be attributed to CVD. To implement a national policy “focusing on the primary health institute and emphasizing prevention” and truly achieve a shift of CVD prevention and treatment from hospitals to communities, the National Center for Cardiovascular Diseases has organized experts from relevant fields across China to compile the “Report on Cardiovascular Health and Diseases in China” annually since 2005. The 2024 report is established based on representative, published, and high-quality big-data research results from cross-sectional and cohort population epidemiological surveys, randomized controlled clinical trials, large sample registry studies, and typical community prevention and treatment cases, along with data from some projects undertaken by the National Center for Cardiovascular Diseases. These firsthand data not only enrich the content of the current report but also provide a more timely and comprehensive reflection of the status of CVD prevention and treatment in China.
2
Identification of Critical Intervention Windows for Central Obesity from Childhood to Early Adulthood: A 30-year Longitudinal Study in China
(30 day view times: 45)
2026, 39(4): 396-407.
doi: 10.3967/bes2026.027
3
Interpretation of Annual Report on Cardiovascular Health and Diseases in China 2024
(30 day view times: 37)
2025, 38(8): 893-917.
doi: 10.3967/bes2025.099
Cardiovascular diseases (CVD) and their risk factors are exerting an increasingly significant impact on public health, and the incidence rate of CVD continues to rise. This article provides an interpretation of essentials from the newly published Annual Report on Cardiovascular Health and Diseases in China (2024), aiming to offer scientific evidence for CVD prevention, treatment, and the formulation of relevant policies.
4
Association between Dietary Diversity during Pregnancy and Gestational Diabetes Mellitus: A Prospective Cohort Study
(30 day view times: 37)
2026, 39(4): 418-426.
doi: 10.3967/bes2025.160
5
Cardiovascular Health and Disease Report in China: Two Decades of Progress
(30 day view times: 33)
2025, 38(8): 891-892.
doi: 10.3967/bes2025.098
6
Heat Wave and Mortality Burden of Chronic Kidney Disease: Current Assessment and Future Projection in China
(30 day view times: 24)
2026, 39(4): 464-475.
doi: 10.3967/bes2026.013
7
Association between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study
(30 day view times: 21)
2026, 39(4): 427-436.
doi: 10.3967/bes2026.005
8
Association of Planetary Health Diet with Decreased Risk of All-cause Mortality and Environmental Benefits: Insights from a Multi-national Prospective Cohort Study
(30 day view times: 21)
2026, 39(4): 476-481.
doi: 10.3967/bes2026.026
Whether adherence to the Planetary Health Diet (PHD) benefits human and environmental health is less known. We included 131,130 adults from the National Health and Nutrition Examination Survey and UK Biobank. Adherence to the PHD was measured using the Planetary Health Diet Index (PHDI) and mortality was ascertained by linking to national registries. Cox proportional hazards and linear/ordinal logistic regression models were used to analyze the association between PHD and the risk of mortality and environmental impacts, respectively. During a median follow-up of 10.6 years, participants in higher adherence groups (Quartile 2: hazard ratio = 0.88, 95% confidence interval = 0.82–0.95; Quartile 3: 0.87, 0.82–0.93; Quartile 4: 0.70, 0.54–0.92) had a lower risk of mortality, compared to Quartile 1. The relationship between the PHDI and mortality showed linearity in the two cohorts (P = 0.1877 and 0.5456, respectively), and body mass index mediated 11.88% of the relationship. A higher PHDI was associated with lower greenhouse gas emissions but higher freshwater use. Our findings suggest that greater compliance with the PHD reduces mortality risk; however, its benefits for environmental sustainability are less certain.
9
Correlation between Anxiety, Depression, and Sleep Quality in College Students
(30 day view times: 16)
2022, 35(7): 648-651.
doi: 10.3967/bes2022.084
10
Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary
(30 day view times: 16)
2023, 36(8): 669-701.
doi: 10.3967/bes2023.106
In the past 30 years, the accessibility and quality index of medical care have made remarkable progress in China, ranking the first among middle-income countries. Many cardiovascular technologies are at or near the world's leading level, and significant progress has been achieved in China solving the problem of “treatment difficulty” of cardiovascular diseases (CVD). However, due to the prevalence of unhealthy lifestyles among Chinese residents, a huge population with CVD risk factors, accelerated population aging, and other reasons, the incidence and mortality rate of CVD are still increasing, and the turning point of the decline in disease burden has not appeared yet in China. In terms of proportions of disease mortality among urban and rural residents, CVD still ranks the first. In 2020, CVD accounted for 48.00% and 45.86% of the causes of death in rural and urban areas, respectively; two out of every five deaths were due to CVD. It is estimated that the number of current CVD patients in China is around 330 million, including 13 million stroke, 11.39 million coronary heart disease, 8.9 million heart failure, 5 million pulmonary heart disease, 4.87 million atrial fibrillation, 2.5 million rheumatic heart disease, 2 million congenital heart disease, 45.3 million peripheral artery disease, and 245 million hypertension cases. China has entered a new stage of transformation from high-speed development to high-quality development, and the prevention and control of CVD in China should also shift from previous emphasis on scale growth to strategies focusing more on strategic and key technological development in order to curb the trend of increasing incidence and mortality rates of CVD.
11
Total Energy Expenditure in Healthy Middle-aged Chinese Adults with Light-intensity Physical Activity: A Doubly Labeled Water Study
(30 day view times: 16)
2026, 39(4): 482-485.
doi: 10.3967/bes2026.028
12
Hemoglobin Thresholds for Defining Anemia among Healthy Infants Aged 0–5 Months in China: A Population-based Study
(30 day view times: 16)
2026, 39(4): 408-417.
doi: 10.3967/bes2025.144
13
Cardiac Organoids: Emerging Tools for Investigating Environmental Roles in Cardiomyopathy Pathogenesis and Therapeutic Development
(30 day view times: 15)
2026, 39(1): 82-104.
doi: 10.3967/bes2025.104
Human cardiac organoids have revolutionized the study of cardiac development, disease modeling, drug discovery, and regenerative therapies. This review systematically discusses strategies and progress in the construction of cardiac organoids, categorizing them into three main types: cardiac spheroids, self-organizing/assembloid organoids, and organoid-on-a-chip systems. This review uniquely integrates the advances in vascularization, organ-on-chip design, and environmental cardiotoxicity modeling within cardiac organoid platforms, offering a critical synthesis that is absent in the literature. In the context of escalating environmental threats to cardiovascular health, there is an urgent need for physiologically relevant models to accurately identify cardiac toxicants and elucidate their underlying mechanisms of action. This review highlights advances in cardiac organoid applications for disease modeling—including congenital heart defects and acquired cardiovascular diseases—drug development, toxicity screening, and the study of environmentally induced cardiovascular pathogenesis. In addition, it critically examines ongoing challenges and underscores opportunities brought by bioengineering approaches. Finally, we propose future directions for developing standardized cardiac organoid platforms with clinical predictability, aiming to expand the utility of this technology across broader research applications.
14
Compound Temperature–humidity Extremes Increase Acute Mental Health Outcomes: A 12-year Case-crossover Metropolitan Study
(30 day view times: 15)
2026, 39(4): 493-498.
doi: 10.3967/bes2025.150
15
A Nationwide Analysis of Key Environmental Determinants Shaping the Spatial Distribution of Kashin-Beck Disease in China
(30 day view times: 15)
2026, 39(5): 609-615.
doi: 10.3967/bes2026.030
16
Modifying Effect of Wind Speed on the Temperature-humidity Interaction Impacting Hand, Foot, and Mouth Disease as Assessed by Years Lived with Disability in Western China
(30 day view times: 14)
2026, 39(5): 529-540.
doi: 10.3967/bes2026.008
17
Association of Ambient PM2.5 Components with Lung Function in Adults Aged 40–89 Years: A Cross-sectional Study in China
(30 day view times: 14)
2026, 39(5): 584-590.
doi: 10.3967/bes2026.039
This study evaluated the impact of Particulate Matter 2.5 (PM2.5) and its components on lung function. In total, 2,045 participants aged 40–89 years were recruited for this multi-center cross-sectional study. Lung function measurements were performed. Real-time PM2.5 and its component data were obtained from atmospheric monitoring sites. Linear mixed-effects (LME) models were used to assess the relationships between PM2.5, its components, and lung function. Weighted quantile sum regression, quantile g-computation, and Bayesian kernel machine regression were applied to assess the joint effects of PM2.5 components on lung function. The mean PM2.5 concentration during the study period was 71.92 μg/m3. Among PM2.5 components, nitrate had the highest mean concentration (16.82 μg/m3), followed by organic carbon and sulfate. In the LME models, PM2.5 exposure at a 1-day lag, scaled to its interquartile range, was significantly related to decreased lung function. Specifically, forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), one-second rate (FEV1/FVC), peak expiratory flow (PEF), and forced expiratory flow at 25% FVC (FEF25%) decreased by 3.75%, 6.56%, 2.89%, 10.48%, and 8.71%, respectively. An age-stratified analysis showed stronger negative associations among participants aged ≥ 60 years compared with middle-aged adults. In mixed-exposure models, the PM2.5 mixture was significantly linked to a decline in lung function. Zinc (Zn) and magnesium ion (Mg2+) were significantly linked to reduced FVC and ammonium ion (NH4+) was identified as a key contributor to reduced FEV1, PEF, and FEF75%. Lung function declined with increasing PM2.5 and its components. Zn, Mg2+, and NH4+ were identified as key components.
18
Low Cardiac Output Augmentation during Exercise Stress Echocardiography at Low Altitude Predicts High Risk of Acute Mountain Sickness
(30 day view times: 14)
2026, 39(5): 541-552.
doi: 10.3967/bes2026.014
19
Short-term Ozone Exposure and Its Impact on Mortality Risk from Circulatory System Diseases: A Comparative Analysis Based on Multi-source Data
(30 day view times: 14)
2026, 39(5): 501-511.
doi: 10.3967/bes2026.036
20
The Global, Regional, and National Burden of Cardiovascular Diseases Attributable to Household Air Pollution from 1990 to 2021: Findings from the Global Burden of Disease Study 2021
(30 day view times: 14)
2026, 39(4): 447-463.
doi: 10.3967/bes2025.141





Quick Links